筛选
科学数据
统计数据
共检索到4条 ,权限内显示50条;
![](http://agri.nais.net.cn/resources/front/images/source_91.jpg)
Data from: Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved
- 负责人:
- 关键词:
- DOI:
- doi:10.5061/dryad.t8n07
- 摘要:
- % (IQR 0–100%) were FDAAA-compliant. 68% of research participants (67?629 of 99?599) participated in FDAAA-subject trials, with 51% (33?405 of 67?629
![](http://agri.nais.net.cn/resources/front/images/source_91.jpg)
Data from: Sharing of clinical trial data among trialists: a cross sectional survey
- 负责人:
- DOI:
- doi:10.5061/dryad.6544v
- 摘要:
- rectly collaborating with the research team. Design and setting: Cross sectional, web based survey. Participants: Clinical trialists who were correspondi
![](http://agri.nais.net.cn/resources/front/images/source_91.jpg)
Data from: A reference set of curated biomedical data and metadata from clinical case reports
- 负责人:
- Caufield, J. Harry
- DOI:
- doi:10.5061/dryad.r36cn90
- 摘要:
- of rare diseases. We also prepared a subset of metadata on reports on selected mitochondrial diseases and assigned ICD-10 diagnostic codes to each. The result
![](http://agri.nais.net.cn/resources/front/images/source_91.jpg)
Data from: A novel algorithm to enhance P300 in single trials: application to lie detection using F-score and SVM
- 负责人:
- DOI:
- doi:10.5061/dryad.2qc64
- 摘要:
- The investigation of lie detection methods based on P300 potentials has drawn much interest in recent years. We presented a novel al
首页上一页1下一页尾页